MedTrace Logo

Proficiency-Based Progression Training for Clinical Communication

NCT02886754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2017-07-25

No results posted yet for this study

Summary

Importance: Clinical communication is an important source of medical error and preventable adverse events.

Objective: To determine the effectiveness of proficiency-based progression (PBP) simulation training for ISBAR (Identify, Situation, Background, Assessment, Recommendation) communication in the deteriorating patient.

Setting: The study will be conducted in University College Cork, Ireland. Participants: Third year undergraduate nursing and fifth year medical students, who are scheduled to undertake ISBAR training as part of the National Early Warning Score (NEWS) programme.

Intervention: Participants will be prospectively randomized to one of three groups before undertaking a performance assessment of an ISBAR communication relevant to a deteriorating patient in a high fidelity simulation laboratory: HSE group (the national e-learning programme only); S group (national e- learning plus simulation training) and PBP group (national e-learning plus proficiency-based progression simulation).

Main outcome and measures: A proficiency benchmark on the performance of ISBAR communication in the context of an acutely deteriorating patient.

Conditions

  • Clinical Communication
  • ISBAR
  • Simulation
  • Proficiency-Based Progression
  • Non Technical Skills
  • Performance
  • Deteriorating Patient

Interventions

BEHAVIORAL

Proficiency-based progression

Use of validated metrics and performance benchmarks to simulation training

BEHAVIORAL

National e-learning programme only

National e-learning programme (COMPASS)

BEHAVIORAL

Standard simulation

Paper based simulation cases

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Anthony Gallagher, PhD, DSc · University College Cork, College Rd, Cork Ireland

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-14
Primary Completion
2016-09-16
Completion
2016-09-16

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02886754 on ClinicalTrials.gov